Kyverna Therapeutics, Inc. (KYTX) Investors: February 7, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Portfolio Pulse from
A securities class action lawsuit has been filed against Kyverna Therapeutics, Inc. (NASDAQ: KYTX) for investors who purchased stock related to its February 8, 2024 IPO. The filing deadline is February 7, 2025.
December 27, 2024 | 3:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Kyverna Therapeutics faces a securities class action lawsuit related to its February 2024 IPO. Investors have until February 7, 2025, to file claims.
The lawsuit could negatively impact Kyverna's stock price as it may lead to financial liabilities and damage investor confidence. The high relevance and importance are due to the direct legal implications for the company.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100